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Vascular soluble guanylate cyclase (sGC) exists in mul-
timeric complexes with endothelial nitric oxide synthase
(eNOS) and heat shock protein 90 (hsp90). Whereas dis-
ruption of hsp90-eNOS complexes clearly attenuates
eNOS-depended vascular relaxation, the contribution of
sGC-hsp90 complexes to eNOS- or NO donor-dependent
relaxations remains controversial. Isolated rat thoracic
aortic rings were pre-incubated with structurally diverse
hsp90 inhibitors, radicicol (RA) or geldanamycin (GA) or
vehicle for 0.5, 1 or 15 hrs and exposed to ACh, 8-Br-
cGMP, forskolin or one of three NO donors: nitroglycerin
(NTG), sodium nitroprusside (SNP) or spermine nonoate
(SNN). Both RA and GA inhibited endothelium-depend-
ent relaxations dose-dependently. Long-term (15 hrs.)
exposure to RA inhibited all NO donor-induced relaxa-
tions; however GA inhibited SNN-induced relaxation
only. 15 hrs. exposure to RA, but not to GA, decreased
hsp90-bound sGC protein expression and NTG-stimu-
lated cGMP formation in aortic rings, whereas RA more
than GA reduced SNN-stimulated cGMP formation. Thus
hsp90 inhibitors selectively inhibit sGC-dependent relax-
ations of aortic rings by reducing sGC expression, disrupt-
ing sGC-hsp90 complex formation and decreasing cGMP
formation. Since hsp90 inhibitors promote proteasomal
degradation of hsp90 client proteins, we then investigated
whether CHIP, a chaperone-dependent ubiquitin E3
ligase, could play a role in the process of degradation of
sGC. Transient overexpression of CHIP in Cos-7 or rat aor-
tic smooth muscle cells degraded sGC and this was abro-
gated by the proteasome inhibitor, MG 132 in a TPR- and
U-box domain-sensitive manner. Co-immunoprecipita-
tion and immunofluorescent studies suggest that CHIP is
associated with sGC, hsp90 and hsp70 and increased the
association of hsp70 with sGC. Furthermore, CHIP
directly ubiquitinated sGC and this was potentiated by
geldanamycin and was followed by proteasomal degrada-
tion. Ad-CHIP infected rat aortic rings exhibited a
decreased SNN-induced relaxation. Taken together, these
studies suggest that hsp90 is a physiologic regulator of
sGC vascular function.
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